Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis

Eur Neurol. 2000;43(3):186-7. doi: 10.1159/000008163.

Authors

S Cursiefen¹, P Flachenecker, K V Toyka, P Rieckmann

Affiliation

¹ Department of Neurology, University of Würzburg, Germany.

PMID: 10765063
DOI: 10.1159/000008163

No abstract available

MeSH terms

Adult
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Male
Middle Aged
Mitoxantrone / administration & dosage*
Mitoxantrone / adverse effects
Multiple Sclerosis, Chronic Progressive / drug therapy*
Multiple Sclerosis, Chronic Progressive / immunology
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Multiple Sclerosis, Relapsing-Remitting / immunology
Neurologic Examination / drug effects
Treatment Outcome

Substances

Immunosuppressive Agents
Mitoxantrone